Patent · US Active

Substituted pyrido[2,3-b]pyrazine compounds as modulators of tyrosine kinases

US8202883B2 · kind B2 · utility

2Cited by

1References

24Claims

0Family size

Assignee

Aeterna Zentaris, Inc. · DE

Inventors

Matthias Gerlach · Wächtersbach, DE
Irene Seipelt · Offenbach, DE
Eckhard Guenther · Maintal, DE
Emmanuel Polymeropoulos · Frankfurt, DE
Tilmann Schuster · Großostheim, DE
Eckhard Claus · Frankfurt, DE

Key dates

Filing date	May 9, 2008
Grant date	Jun 19, 2012
Priority date	—
Expiry date	May 29, 2029

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P43/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to pyrido[2,3-b]pyrazine compounds of formulae (Ia) and (Ib) which have activity to the modulation of misdirected cellular signal transduction processes such as tyrosine kinases, serine/threonine kinases and/or lipid kinases, their preparation and use as medicaments, especially for the treatment of malignant disorders and other disorders based on pathological cell proliferations:

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.